Supplemental material
Open access
6,873
Views
149
CrossRef citations to date
0
Altmetric
Report
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques
Daniel Ayoub Centre d'Immunologie Pierre Fabre; St Julien-en-Genevois, FranceCorrespondence[email protected] [email protected] [email protected]
, Wolfgang Jabs Bruker Daltonik GmbH; Bremen, GermanyCorrespondence[email protected] [email protected] [email protected]
, Anja Resemann Bruker Daltonik GmbH; Bremen, Germany
, Waltraud Evers Bruker Daltonik GmbH; Bremen, Germany
, Catherine Evans Bruker Daltonics GmbH;Fällanden, Switzerland
, Laura Main Bruker Daltonics Ltd.; Coventry, UK
, Carsten Baessmann Bruker Daltonik GmbH; Bremen, Germany
, Elsa Wagner-Rousset Centre d'Immunologie Pierre Fabre; St Julien-en-Genevois, France
, Detlev Suckau Bruker Daltonik GmbH; Bremen, Germany
& Alain Beck Centre d'Immunologie Pierre Fabre; St Julien-en-Genevois, FranceCorrespondence[email protected] [email protected] [email protected]
show all
Pages 699-710
|
Received 08 May 2013, Accepted 15 Jun 2013, Published online: 20 Jun 2013
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.